GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Long-Term Capital Lease Obligation

Philogen SpA (STU:78Q) Long-Term Capital Lease Obligation : €10.47 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Long-Term Capital Lease Obligation?

Philogen SpA's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was €10.47 Mil.

Philogen SpA's quarterly Long-Term Capital Lease Obligation declined from Dec. 2023 (€11.10 Mil) to Jun. 2024 (€10.46 Mil) but then increased from Jun. 2024 (€10.46 Mil) to Dec. 2024 (€10.47 Mil).

Philogen SpA's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (€11.02 Mil) to Dec. 2023 (€11.10 Mil) but then declined from Dec. 2023 (€11.10 Mil) to Dec. 2024 (€10.47 Mil).


Philogen SpA Long-Term Capital Lease Obligation Historical Data

The historical data trend for Philogen SpA's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Long-Term Capital Lease Obligation Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Capital Lease Obligation
11.27 11.10 11.02 11.10 10.47

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.02 11.07 11.10 10.46 10.47

Philogen SpA  (STU:78Q) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Philogen SpA Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Long-Term Capital Lease Obligation
Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines